URGN Shares Calculator
Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
shares x $14.26 = $142.6
URGN Charts
URGN Prices
View the URGN historical prices.
52WL $8.69
The 52 Week Low is $8.69 set on Fri, Apr 19, 2024.
52WH $24.13
The 52 Week High is $24.13 set on Fri, Apr 19, 2024. The current price, $14.26, is 0% below the 52 Week High.
ATH $0.00
The All-Time High is $0.00 set on Fri, Apr 19, 2024. The current price, $14.26, is 0% below the All Time High.
52 Week Range
URGN Dividends
URGN has no dividend history.
0.00%
Annual Dividend Yield
$
Quarterly Dividend Rate
--
Declaration Date
--
Ex-Dividend Date
--
Record Date
--
Payment Date
--
Dividend Frequency
0
Dividend History
URGN Profile
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in innovative solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.
